Hemostemix Inc. HMTXF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -456.90K | -575.90K | -1.88M | -420.20K | -165.30K |
| Total Depreciation and Amortization | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 22.50K | -63.80K | -35.20K | -233.80K | 135.70K |
| Change in Net Operating Assets | 159.20K | 45.90K | 1.08M | -1.46M | -549.40K |
| Cash from Operations | -275.20K | -593.80K | -836.30K | -2.11M | -579.10K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -200.00 | 0.00 | 0.00 |
| Cash from Investing | -- | -- | -200.00 | 0.00 | 0.00 |
| Total Debt Issued | -- | -- | 749.80K | -- | -- |
| Total Debt Repaid | -- | -- | -1.25M | -- | -- |
| Issuance of Common Stock | 348.60K | 304.00K | 1.19M | 3.38M | 515.10K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 251.80K | 221.60K | 496.10K | 2.46M | 372.30K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -23.40K | -372.20K | -340.40K | 346.80K | -206.80K |